Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Peringkat dalam Saham #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Harga Saham
$93.80
Terakhir disinkronkan: 2025-04-28
Kapitalisasi Pasar
$2.68B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Aerovate Therapeutics, Inc. (AVTE)

Kategori

Riwayat dividen untuk Aerovate Therapeutics, Inc. (AVTE)
Saham Aerovate Therapeutics, Inc. (simbol: AVTE) telah membayar total 1 dividen.
Total semua dividen (disesuaikan dengan stock split): $2.40
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Aerovate Therapeutics, Inc. (AVTE) dari 2025 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
2026 (TTM) $2.40 0.00%
2025 $2.40 0.00%
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
2026 (TTM) $84.00 0.00%
2025 $84.00 0.00%
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH